EVALUATION OF POTENTIAL CAUSES FOR THE INCOMPLETE BIOAVAILABILITY OF FUROSEMIDE - GASTRIC 1ST-PASS METABOLISM

被引：184

作者：

LEE, MG ^{[1
]}

CHIOU, WL ^{[1
]}

机构：

[1] UNIV ILLINOIS,COLL PHARM,DEPT PHARMACODYNAM,CHICAGO,IL 60612

来源：

JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS | 1983年 / 11卷 / 06期

关键词：

D O I：

10.1007/BF01059061

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：623 / 640

页数：18

共 45 条

[21]

HONARI J, 1977, CLIN PHARMACOL THER, V22, P395

[22]

HUANG CM, 1974, CLIN PHARMACOL THER, V16, P659

HUANG, SM ;

HUANG, YC ;

CHIOU, WL .

JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1981, 9 (06) :725-738

INUI, S ;

YAMAMOTO, M ;

NAKAE, H ;

ASADA, S .

YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 1982, 102 (11) :1053-1060

[25]

KELLY MR, 1977, CURR THER RES CLIN E, V21, P1

[26]

KELLY MR, 1974, CLIN PHARMACOL THER, V15, P178

[27]

KWAN KC, 1979, J PHARM SCI, V7, P527

[28]

LAMBERT C, 1982, J PHARMACOL EXP THER, V222, P232

[29]

LEE MG, 1981, RES COMMUN CHEM PATH, V34, P17

[30]

LEE MG, 1982, THESIS U ILLINOIS CH